TY  - JOUR
TI  - European guidelines for personality disorders: past, present and future
UR  - https://archiv.ub.uni-heidelberg.de/volltextserver/26481/
IS  - 9
CY  - London
JF  - Borderline Personality Disorder and Emotion Dysregulation
AV  - public
Y1  - 2019///
SP  - 1
A1  - Simonsen, Sebastian
A1  - Bateman, Anthony
A1  - Bohus, Martin
A1  - Dalewijk, Henk Jan
A1  - Doering, Stephan
A1  - Kaera, Andres
A1  - Moran, Paul
A1  - Renneberg, Babette
A1  - Ribaudi, Joaquim Soler
A1  - Taubner, Svenja
A1  - Wilberg, Theresa
A1  - Mehlum, Lars
ID  - heidok26481
SN  - 2051-6673
EP  - 10
N2  - Personality disorders (PD) are common and burdensome mental disorders. The treatment of individuals with PD represents one of the more challenging areas in the field of mental health and health care providers need evidence-based recommendations to best support patients with PDs. Clinical guidelines serve this purpose and are formulated by expert consensus and/or systematic reviews of the current evidence. In this review, European guidelines for the treatment of PDs are summarized and evaluated. To date, eight countries in Europe have developed and published guidelines that differ in quality with regard to recency and completeness, transparency of methods, combination of expert knowledge with empirical data, and patient/service user involvement. Five of the guidelines are about Borderline personality disorder (BPD), one is about antisocial personality disorder and three concern PD in general. After evaluating the methodological quality of the nine European guidelines from eight countries, results in the domains of diagnosis, psychotherapy and pharmacological treatment of PD are discussed. Our comparison of guidelines reveals important contradictions between recommendations in relation to diagnosis, length and setting of treatment, as well as the use of pharmacological treatment. All the guidelines recommend psychotherapy as the treatment of first choice. Future guidelines should rigorously follow internationally accepted methodology and should more systematically include the views of patients and users.
VL  - 6
PB  - BioMed Central
ER  -